USPTO serial 88125522
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML)
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 8, 2020
- Examiner
- GANESH, HARINI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML)?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $650
Owner
Sun Pharmaceutical Industries Limited
Mumbai, Maharashtra, IN
Other trademarks owned by Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
Mumbai, Maharashtra, IN
Other trademarks owned by Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
Mumbai, Maharashtra, IN
Other trademarks owned by Sun Pharmaceutical Industries Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Craig Kuchii, Esq.
Craig Kuchii, Esq. SUN PHARMACEUTICAL INDUSTRIES, INC.2 INDEPENDENCE WAYINTELLECTUAL PROPERTY DEPT.PRINCETON, NJ 08540Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine | ACTIVE | Jul 8, 2020 |
| 010 | medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine | ACTIVE | Jul 8, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sun Pharmaceutical Industries Limited
- Other trademarks owned by Sun Pharmaceutical Industries Limited
- Other trademarks owned by Sun Pharmaceutical Industries Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML)
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 8, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 8, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 4, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 3, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 23, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 13, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 13, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 29, 2020 | IUAF | USE AMENDMENT FILED | — |
| Sep 29, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 24, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 22, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 22, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 22, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 25, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 23, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 23, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 23, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 23, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 26, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 26, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 6, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 18, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 15, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 15, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 15, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 15, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 14, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 8, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 21, 2018 | ALIE | ASSIGNED TO LIE | — |
| Nov 29, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 29, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 29, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 29, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 28, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 26, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 24, 2018 | NWAP | NEW APPLICATION ENTERED | — |